Table 5. Features of recombinant allergen-based vaccines.

Contain defined amounts of well-characterized molecules

Allergenic and immunogenic activity of components is known

Formulation of composite vaccines for large populations but also of vaccines for patient-tailored therapy possible

Can be produced in large amounts, at low costs, according to high quality standards

Meet current quality guidelines required for vaccines

But,

So far only few clinical studies performed

No registered product available